ReviewPatient preference and adherence2015

Patient considerations in the treatment of COPD: focus on the new combination inhaler umeclidinium/vilanterol.

Timothy E Albertson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.